NICOLE MOSELEY-JONES: Open Payments
NPI 1972064434 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 39 payments from 9 companies in 2025. Trend: 2023 $680 · 2024 $957 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $403 |
| E.R. Squibb & Sons, L.L.C. | 8 | $259 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $151 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
| Janssen Pharmaceuticals, Inc | 2 | $71 |
| Lundbeck LLC | 3 | $68 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $15 |
Products named: ABILIFY ASIMTUFII, COBENFY, CAPLYTA, REXULTI, SPRAVATO, UZEDY, INGREZZA, Auvelity.
Industry payments across NY — which companies pay providers there.
